Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Current report (Form 8-K) · Jun 4, 2026 · Restructuring or layoffs · Other material event
| ItemItem | Disclosure |
|---|---|
| Item 2.05 | Recorded exit or disposal costs (restructuring, layoffs, closures) |
| Item 8.01 | Other events the company considers material |
Fulcrum Therapeutics, Inc. filed this because it recorded material costs from a restructuring, layoff, facility closure, or similar exit activity that investors must be told about promptly.
) 26 Landsdowne Street Cambridge , Massachusetts 02139 (Address of principal executive offices) (Zip Code) Registrant’s telephone number, including area code: (617) 651-8851 N/A (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230. 425) ☐ Soliciting materi…
This filing reports Item 2.05 (recorded exit or disposal costs (restructuring, layoffs, closures)); Item 8.01 (other events the company considers material). These item codes often precede or accompany restructuring, leadership changes, or deals that can shift headcount.
Fulcrum Therapeutics, Inc. reported material events that can affect workforce planning. cutoffs surfaces the filing alongside WARN layoffs, H-1B activity, and company signals.